- Q1 10
- Q2 4
- Q3 2
- Q4 3
Akademisyen
HASİP KAHRAMAN
DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Pneumonia and Respiratory Infections6
- Infectious Diseases and Tuberculosis4
- Bacterial Infections and Vaccines3
- Hepatitis Viruses Studies and Epidemiology2
- Urinary Tract Infections Management2
- Orthopedic Infections and Treatments2
- Antimicrobial Resistance in Staphylococcus2
- Neutropenia and Cancer Infections2
- Pneumocystis jirovecii pneumonia detection and treatment2
- Infective Endocarditis Diagnosis and Management2
- Bacterial Identification and Susceptibility Testing2
- Mosquito-borne diseases and control2
Atıf etkisi
OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 26- i10-indeks
- 7
- Toplam atıf
- 284 Türkiye’de üst %19
- Makale başına
- 10,9
- FWCI
- 1,11 1,00 = dünya ortalaması
- Dünyada üst %1
- 0
- Dünyada üst %10
- 2
En çok atıf alan makaleleri
- The burden and epidemiology of community-acquired central nervous system infections: a multinational study
- Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)—based survey
- Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: Results of the Ege study
h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.
Alan sıralaması
YÖKSİS ?-
Ana dal Sağlık Bilimleri Temel AlanıPuan sırası #12.548/ 43.834 üst %28,6Puan 18,25 dergi 18 · OA ek 0,25
- Makale sırası15.788/43.834
- Scopus sırası12.815/43.834
- WoS sırası10.258/43.834
- YÖKSİS27
- Scopus19
- WoS23
-
Yan dal Enfeksiyon Hastalıkları ve Klinik MikrobiyolojiPuan sırası #202/ 497 üst %40,6Puan 18,25 dergi 18 · OA ek 0,25
- Makale sırası228/497
- Scopus sırası207/497
- WoS sırası191/497
- YÖKSİS27
- Scopus19
- WoS23
Dizin çeyrekleri
?- Q1 3
- Q2 6
- Q3 5
- Q4 9
13 makale
- Üst %1 0
- Üst %10 2
- Ort. 58.4%
- n 26
Diğer sayımlar
Scopus (SJR)
- YÖKSİS satırı 19
WoS (JCR)
- YÖKSİS satırı 23
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Yayını olan dergiler
20 dergi
- 1300-932X 4
- Mediterranean Journal of Infection, Microbes and Antimicrobials 3
- 1301-3114 2
- European Journal of Clinical Microbiology and Infectious Diseases 2
- 1305-4953 1
- 2146-3158 1
- Antibiotics 1
- Antimicrobial Resistance and Infection Control 1
- BMC Infectious Diseases 1
- Clinical Neurology and Neurosurgery 1
- IJID Regions 1
- Infection 1
- Infection and Drug Resistance 1
- Infectious Diseases Now 1
- International Journal of Infectious Diseases 1
- Journal of Clinical Virology 1
- Mikrobiyoloji Bulteni 1
- Scientific Reports 1
- Tuberkuloz ve Toraks 1
- Viruses 1
Makale listesi
- 2025 Managing penicillin resistant pneumococcal meningitis: an international id-iri study YÖKSİS SJR Q1 JCR Q2 OpenAlex 72.1%
- 2025 Comparative Clinical Outcomes of Major Respiratory Viruses in Hospitalized Adults During the Post-Pandemic Period: A Retrospective Cohort Study YÖKSİS SJR Q1 JCR Q2 OpenAlex 87.1%
- 2025 Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status YÖKSİS SJR Q1 JCR Q2 OpenAlex 85.3%
- 2025 Extended-Spectrum Beta-Lactamase Production and Carbapenem Resistance in Elderly Urinary Tract Infection Patients: A Multicenter Retrospective Study from Turkey YÖKSİS SJR Q1 JCR Q1 OpenAlex 20.0%
- 2025 Bloodstream Infections in Non-ICU Hospitalized Patients: Impact of Pathogen Group on Clinical Outcomes-A Retrospective Cohort Study From Türkiye. YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.6%
- 2025 Yoğun Bakım Ünitesinde Erken Dönem Kültür Pozitifliği, Ampirik Tedavi ve Mortalite İlişkisi YÖKSİS TR Index JCR Q4 OpenAlex 52.5%
- 2025 Chronic Coxiella burnetii Infection in a Patient with a Left Ventricular Assist Device: A Case Report YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 69.8%
- 2025 Risk Factors and Treatment Determinants of Mortality in Carbapenem-Resistant Gram-Negative Bloodstream Infections in the Intensive Care Unit YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 25.4%
- 2025 Mortality Associated with Surgical Site Infections Following Cardiac Surgery: Insights from the International ID-IRI Study YÖKSİS SJR Q2 JCR Q3 OpenAlex 82.2%
- 2024 The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study YÖKSİS SJR Q1 JCR Q1 OpenAlex 64.2%
- 2024 Erişkin Bağışıklamada Kaçan Fırsatlar YÖKSİS TR Index OpenAlex 72.2%
- 2024 Kan Dolaşımı İnfeksiyonlarının Önlenmesinde Demet Programlarına Uyumun Değerlendirilmesi YÖKSİS TR Index JCR Q4 OpenAlex 6.0%
- 2023 Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)—based survey YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.4%
- 2022 Aile Hekimleri ve Tıp Fakültesi Öğrencileri Kronik Hepatit C İnfeksiyonunun Farkında Mı? YÖKSİS TR Index JCR Q4 OpenAlex 44.0%
- 2021 Daptomycin versus teicoplanin in the treatment of osteomyelitis: Results of the Göztepe retrospective cohort study YÖKSİS SJR Q2 JCR Q3 OpenAlex 64.6%
- 2020 Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – Result of a multinational ID-IRI study YÖKSİS SJR Q1 JCR Q3 OpenAlex 87.0%
- 2020 A challenge of differential diagnosis: Neurological involvement in a HIV positive case YÖKSİS TR Index OpenAlex 6.9%
- 2019 Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study YÖKSİS SJR Q1 JCR Q2 OpenAlex 54.4%
- 2019 When to start prophylaxis? A Human Immunodeficiency Virus Syndrome Case Presenting with Upper Extremity Weakness YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 14.9%
- 2018 Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: Results of the Ege study YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.0%